Bill

Bill > HB2020


PA HB2020

PA HB2020
Further providing for drug overdose response immunity.


summary

Introduced
02/07/2024
In Committee
02/07/2024
Crossed Over
Passed
Dead
12/31/2024

Introduced Session

2023-2024 Regular Session

Bill Summary

Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for drug overdose response immunity.

AI Summary

This bill amends the Controlled Substance, Drug, Device and Cosmetic Act to further provide for drug overdose response immunity. The key provisions are: (1) a person who transported or reported and remained with someone experiencing a drug overdose event cannot be charged or prosecuted, and (2) a person who experienced a drug overdose event cannot be charged or prosecuted if, within 30 days, they participate in a drug treatment program ordered by the parole board or the court. However, the immunity can be revoked if the person fails to participate in the mandated drug treatment program.

Committee Categories

Justice

Sponsors (5)

Last Action

Referred to JUDICIARY (on 02/07/2024)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Criminal and Juvenile Delinquent Prosecution, Procedure, and Sentencing

bill text


bill summary

Loading...

bill summary

Loading...
Loading...